Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Cancer Research|November 13, 2003
The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activityPaolo Monti, Biagio Eugenio Leone, Federica Marchesi, et al.
Pharmacological Research|April 4, 2018
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trialDavide Pastorelli, Aline S C Fabricio, Petros Giovanis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 1, 2016
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitusStefania Moz, Daniela Basso, Andrea Padoan, et al.
Nature Communications|November 24, 2017
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survivalMarco Segatto, Raffaella Fittipaldi, Fabrizio Pin, et al.
Pancreas|December 29, 2012
Usefulness of MALDI-TOF/MS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancerAndrea Padoan, Roberta Seraglia, Daniela Basso, et al.
Cancers|February 26, 2025
Cystic Fluid Total Proteins, Low-Density Lipoprotein Cholesterol, Lipid Metabolites, and Lymphocytes: Worrisome Biomarkers for Intraductal Papillary Mucinous NeoplasmsFahimeh Jafarnezhad-Ansariha, Nicole Contran, Chiara Cristofori, et al.
Cell Reports. Medicine|December 5, 2023
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophyErica Mina, Elisabeth Wyart, Roberta Sartori, et al.
European Journal of Haematology|November 15, 2020
Histology of the spleen in immune thrombocytopenia: clinical-pathological characterization and prognostic implicationsMarco Pizzi, Alberto Friziero, Fabrizio Vianello, et al.
Plos One|January 30, 2013
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro studyDaniela Basso, Paola Fogar, Massimo Falconi, et al.
Carcinogenesis|January 11, 2019
Genetic variability of the ABCC2 gene and clinical outcomes in pancreatic cancer patientsManuel Gentiluomo, Paula Puchalt García, Alice Alessandra Galeotti, et al.
Pageof 10